| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |